
    
      Therapeutic advances in the arena of neovascular age-related macular degeneration (AMD) have
      provided multiple treatment options for the disease. Radiotherapy has been studied in
      multiple clinical trials in the past with many studies showing a therapeutic benefit.
      Treatment with radiotherapy and anti-VEGF compounds is a promising approach to treating AMD.
    
  